Renal Histologic Analysis Provides Complementary Information to Kidney Function Measurement for Patients with Early Diabetic or Hypertensive Disease
暂无分享,去创建一个
K. Suszták | Ziyuan Ma | Hongbo Liu | A. Cucchiara | A. Havasi | M. Palmer | G. Quinn | A. Abedini | Jon Hill | Ghazal Z. Quinn
[1] R. Townsend,et al. The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort , 2021, Kidney international reports.
[2] S. Waikar,et al. Risk Factors for CKD Progression: Overview of Findings from the CRIC Study. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[3] D. Leaf,et al. Histopathologic Correlates of Kidney Function: Insights From Nephrectomy Specimens. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] David S Jones,et al. Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms. , 2020, The New England journal of medicine.
[5] B. Astor,et al. Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients , 2020, Canadian journal of kidney health and disease.
[6] Michael T. Eadon,et al. Kidney Histopathology and Prediction of Kidney Failure: A Retrospective Cohort Study. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] A. Davenport,et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. , 2020, Kidney international.
[8] David L. Birtwell,et al. Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways. , 2020, Kidney international.
[9] R. Townsend,et al. Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. , 2020, Kidney international.
[10] Wei Yang,et al. Reconsidering the Consequences of Using Race to Estimate Kidney Function. , 2019, JAMA.
[11] K. Ohashi,et al. Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] Z. Botta‐Dukát,et al. Silhouette width using generalized mean—A flexible method for assessing clustering efficiency , 2018, bioRxiv.
[13] Anand Srivastava,et al. The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. , 2018, Journal of the American Society of Nephrology : JASN.
[14] M. Woodward,et al. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. , 2018, Kidney international.
[15] J. Gaut,et al. Renal Histopathologic Findings Associated With Severity of Clinical Acute Kidney Injury , 2018, The American journal of surgical pathology.
[16] Chengxiang Qiu,et al. Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits , 2017, EBioMedicine.
[17] J. Roy,et al. Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[18] Jai Radhakrishnan,et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. , 2017, Kidney international.
[19] Yufeng Liu,et al. Statistical significance for hierarchical clustering , 2014, Biometrics.
[20] D. Rybin,et al. Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts , 2016, American Journal of Nephrology.
[21] A. Go,et al. Inflammation and Progression of CKD: The CRIC Study. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[22] S. Hewitt,et al. Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images , 2016, Modern Pathology.
[23] M. Breyer,et al. The next generation of therapeutics for chronic kidney disease , 2016, Nature Reviews Drug Discovery.
[24] M. Rudnicki,et al. A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases , 2014, BMC Medical Genomics.
[25] J. Coresh,et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.
[26] Katalin Susztak,et al. Molecular mechanisms of diabetic kidney disease. , 2014, The Journal of clinical investigation.
[27] N. Tangri,et al. A predictive model for progression of chronic kidney disease to kidney failure. , 2011, JAMA.
[28] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[29] Paul A Murtaugh,et al. Performance of several variable-selection methods applied to real ecological data. , 2009, Ecology letters.
[30] Fernand,et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.
[31] Samy Suissa,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[32] M. Nangaku. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.
[33] T. Meyer,et al. Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.
[34] K. Nath,et al. Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] N. Duan. Smearing Estimate: A Nonparametric Retransformation Method , 1983 .